Risk of lymphoma in autoimmune rheumatic conditions [4]

Archives of Internal Medicine

Volumn 166, Issue 11, 2006, Pages 1233-1234

  Bernatsky, Sasha ^a   Clarke, Ann ^b   Ramsey Goldman, Rosalind ^b  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE DISEASE; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; LETTER; LYMPHOMA; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RHEUMATIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

AUTOIMMUNE DISEASES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOMA, NON-HODGKIN; RHEUMATIC DISEASES; RISK FACTORS;

EID: 33745041448     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.166.11.1233-b     Document Type: Letter

References (2)

1. Zintzaras E, Voulgarelis M, Moutsopoulos HM. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med. 2005;165:2337-2344.
2. Bernatsky S, Boivin JF, Joseph L, et al. An international cohort study of cancer in systemic lupus erythematosus. Arthritis Rheum. 2005;52:1481-1490.